 |
|
 |
- May 13, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Biography |
|
|
Dr. Sheldon Tobe
A graduate in medicine from the University of Calgary, Dr. Sheldon Tobe served his internship and residencies in internal medicine at the University of Toronto teaching hospitals from 1985-1988. This was closely followed by a one year term as resident in nephrology at the Toronto Hospital, where, in 1993, he completed a three-year MRC research fellowship in nephrology.
Since 1993, Dr. Tobe has combined his position as staff nephrologist at the Sunnybrook Health Sciences Centre with that of assistant professor of medicine at the University of Toronto. Dr. Tobe served as principal investigator in a comprehansive research project devoted to bicarbonate dialysis. In addtion to being awarded the 1996 Sunnybrook Health Sciencse Centre Department of Medicine Young Clinician-Teacher Award in 1999 he was appointed Sunnybook’s acting division director in the division of nephrology. He is director as of January, 2000.
A member of various professional and volunteer organizations including serving as medical director for the Kidney Foundation of Canada’s Central Ontario Branch board of directors, Dr. Tobe also sits on numerous committees including the Toronto regional Dialysis Committee, the Canadian Hypertension Society Clinical Practie guideline Committee (renal and renal- vascular subgroup) and the executive of the Ontario Association of Nephrologists.
With an overriding interest in community-based, patient-focused research, Dr. Tobe concentrates his investigation in two-distinct areas. The first is prevention of ESRD in populations at risk (i.e., hypertension and diabtes). The second is prevention of morbidity and mortality in Dialysis.
|
| |
List of presentations from this healthcare provider available on CMEonDiabetes :
 Insulin Resistance, Microalbuminuria and the Kidney
english - 2002-11-16 - 27 minutes
|
|
|
|
|
| Social |
 |
| |
Let others know about this biography.
|
|
| Search our website |
|
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
|
|
